DIFFERENT CYTOPLASMIC STRUCTURE OF THE CD3-ZETA FAMILY DIMER MODULATES THE ACTIVATION SIGNAL AND FUNCTION OF T-CELLS

被引:15
作者
AOE, T [1 ]
GOTO, S [1 ]
OHNO, H [1 ]
SAITO, T [1 ]
机构
[1] CHIBA UNIV,SCH MED,CTR BIOMED SCI,DIV MOLEC GENET,CHUO KU,CHIBA 260,JAPAN
关键词
CD3; COMPLEX; SIGNALING MOTIF; TCR; ZETA FAMILY MOLECULE;
D O I
10.1093/intimm/6.11.1671
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The TCR complex transduces the antigen recognition signal through common activation motifs present in both CD3 gamma delta epsilon chains and zeta dimers within the complex. We have investigated functional roles of the cytoplasmic domain in zeta and CD3 gamma delta epsilon for T cell activation in early and late responses by comparing the signaling capability of the TCR complexes containing mutant zeta lacking some or all motifs, or eta chain, another zeta family molecule. The results with the mutant zeta lacking all motifs indicated that CD3 gamma delta epsilon can transduce signals to cause early activation events and production of IL-2 upon antigen stimulation in the absence of zeta motifs. However, any one of the zeta motifs was required to respond to Thy-1 stimulation and this requirement cannot be replaced by other CD3 chains. Such zeta motif-dependent responses were also observed in tyrosine phosphorylation of a 90 kDa protein upon TCR stimulation. Furthermore, we found that the C-terminal unique region of the eta chain exhibits inhibitory function in phosphorylation and Ca2+ response upon TCR stimulation as well as IL-2 production upon Thy-1 stimulation. Collectively, the present analyses suggest that two types of signals are induced through the TCR-CD3 complex: (i) the common motif-dependent signals which are mediated equally through zeta dimers and CD3 gamma delta epsilon, and (ii) zeta specific motif-dependent signals. Differences in the cytoplasmic domain of zeta family molecules may modulate the cooperation of these two signals, resulting in alteration of T cell functions.
引用
收藏
页码:1671 / 1679
页数:9
相关论文
共 40 条
  • [1] CELL-GROWTH CYCLE BLOCK OF T-CELL HYBRIDOMAS UPON ACTIVATION WITH ANTIGEN
    ASHWELL, JD
    CUNNINGHAM, RE
    NOGUCHI, PD
    HERNANDEZ, D
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (01) : 173 - 194
  • [2] MONOCLONAL CYTOLYTIC T-CELL LINES
    BAKER, PE
    GILLIS, S
    SMITH, KA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 149 (01) : 273 - 278
  • [3] BANIYASH M, 1989, J BIOL CHEM, V264, P13252
  • [4] DIFFERENTIAL SIGNAL TRANSDUCTION VIA T-CELL RECEPTOR CD3-ZETA-2, CD3-ZETA-ETA, AND CD3-ETA-2 ISOFORMS
    BAUER, A
    MCCONKEY, DJ
    HOWARD, FD
    CLAYTON, LK
    NOVICK, D
    KOYASU, S
    REINHERZ, EL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (09) : 3842 - 3846
  • [5] LITHIUM AMPLIFIES AGONIST-DEPENDENT PHOSPHATIDYLINOSITOL RESPONSES IN BRAIN AND SALIVARY-GLANDS
    BERRIDGE, MJ
    DOWNES, CP
    HANLEY, MR
    [J]. BIOCHEMICAL JOURNAL, 1982, 206 (03) : 587 - 595
  • [6] ZAP-70 - A 70 KD PROTEIN-TYROSINE KINASE THAT ASSOCIATES WITH THE TCR ZETA-CHAIN
    CHAN, AC
    IWASHIMA, M
    TURCK, CW
    WEISS, A
    [J]. CELL, 1992, 71 (04) : 649 - 662
  • [7] CD3-ETA AND CD3-ZETA ARE ALTERNATIVELY SPLICED PRODUCTS OF A COMMON GENETIC-LOCUS AND ARE TRANSCRIPTIONALLY AND OR POSTTRANSCRIPTIONALLY REGULATED DURING T-CELL DEVELOPMENT
    CLAYTON, LK
    DADAMIO, L
    HOWARD, FD
    SIEH, M
    HUSSEY, RE
    KOYASU, S
    REINHERZ, EL
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (12) : 5202 - 5206
  • [8] T-CELL RECEPTOR-ZETA CD3-P59(FYN(T))-ASSOCIATED P120/130 BINDS TO THE SH2 DOMAIN OF P59(FYN(T))
    DASILVA, AJ
    JANSSEN, O
    RUDD, CE
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) : 2107 - 2113
  • [9] P59FYN TYROSINE KINASE ASSOCIATES WITH MULTIPLE T-CELL RECEPTOR SUBUNITS THROUGH ITS UNIQUE AMINO-TERMINAL DOMAIN
    GAUEN, LKT
    KONG, ANT
    SAMELSON, LE
    SHAW, AS
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (12) : 5438 - 5446
  • [10] HANSBURG D, 1983, J IMMUNOL, V131, P319